ADVANCED REPARATIVE MEDICINES Trademark

Trademark Overview

On Friday, June 11, 2021, a trademark application was filed for ADVANCED REPARATIVE MEDICINES with the United States Patent and Trademark Office. The USPTO has given the ADVANCED REPARATIVE MEDICINES trademark a serial number of 90768182. The federal status of this trademark filing is REGISTERED as of Tuesday, November 15, 2022. This trademark is owned by Angiocrine Bioscience. The ADVANCED REPARATIVE MEDICINES trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells for medical or clinical use; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of infectious diseases
advanced reparative medicines

General Information

Serial Number90768182
Word MarkADVANCED REPARATIVE MEDICINES
Filing DateFriday, June 11, 2021
Status700 - REGISTERED
Status DateTuesday, November 15, 2022
Registration Number6903184
Registration DateTuesday, November 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCells for medical or clinical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells for medical or clinical use; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of infectious diseases
Disclaimer with Predetermined Text"MEDICINES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code005
First Use Anywhere DateFriday, July 1, 2022
First Use In Commerce DateFriday, July 1, 2022

Trademark Owner History

Party NameAngiocrine Bioscience
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92172
Party NameAngiocrine Bioscience
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92172

Trademark Events

Event DateEvent Description
Tuesday, November 15, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 15, 2022REGISTERED-SUPPLEMENTAL REGISTER
Thursday, October 13, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 7, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, October 6, 2022APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, October 6, 2022USE AMENDMENT ACCEPTED
Tuesday, October 4, 2022AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, October 4, 2022USE AMENDMENT FILED
Tuesday, October 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 3, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, October 3, 2022TEAS AMENDMENT OF USE RECEIVED
Wednesday, September 7, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 7, 2022FINAL REFUSAL E-MAILED
Wednesday, September 7, 2022FINAL REFUSAL WRITTEN
Wednesday, August 17, 2022ATTORNEY REVIEW COMPLETED
Tuesday, August 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 16, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 16, 2022ASSIGNED TO LIE
Tuesday, August 2, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, July 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 9, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 9, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 2, 2022ASSIGNED TO EXAMINER
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 15, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords

medicines reparative advanced cells medical treatment pharmaceutical stem purposes clinical cancer diseases prevention